{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:23:21Z","timestamp":1784647401083,"version":"3.55.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Sarcopenia is closely associated with gastric cancer (GC) prognosis. However, its exact definition remains controversial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This study included computed tomography images and clinical data of patients from three prospective studies. The skeletal muscle index (SMI) and skeletal muscle radiation attenuation (SMRA) were analyzed, and a new muscle parameter, skeletal muscle gauge (SMG), was obtained by multiplying the two parameters. The values of the three indices for predicting the prognosis of patients with GC were compared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The study included 717 patients. The findings showed median values of 42\u00a0cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup> (range, 36.8\u201348.2 cm<jats:sup>2<\/jats:sup>\/m<jats:sup>2<\/jats:sup>) for SMI, 45 HU (range, 41\u201349 HU) for SMRA, and 1842 (range, 1454\u20132260) for SMG. Postoperatively, 111 patients (15.5%) experienced complications. The 3-year overall survival (OS), disease-free survival (DFS), and recurrence-free survival (RFS) were 74.3%, 68.2%, and 70%, respectively. Univariate logistic analysis showed that postoperative complications were associated with SMI (odds ratio [OR] 0.94; 95% confidence interval [CI] 0.92\u20130.96), SMRA (OR, 0.87; 95% CI 0.84\u20130.90), and SMG (OR 0.99; 95% CI 0.98\u20130.99). After a two-step multivariate analysis, only SMG (OR 0.98, 95% CI 0.97\u20130.99) was an independent protective factor of postoperative complications. Multivariate analysis showed that SMG also was an independent protective factor of OS, DFS, and RFS. The patients were divided into low-SMG (L-SMG) group and high-SMG (H-SMG) groups. Chemotherapy benefit analysis of the patients with stage II low SMG showed that the OS, DFS, and RFS of the chemotherapy group were significantly better than those of the non-chemotherapy group (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The prospective large sample data showed that the new muscle parameter, SMG, can effectively predict the short-term outcome and long-term prognosis of patients with resectable gastric cancer. As a new muscle parameter index, SMG is worthy of further study.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1245\/s10434-024-14913-w","type":"journal-article","created":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T14:15:58Z","timestamp":1706192158000},"page":"3005-3016","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predictive Value of a New Muscle Parameter in Patients with Resectable Gastric Cancer: A Pooled Analysis of Three Prospective Trials"],"prefix":"10.1245","volume":"31","author":[{"given":"Qing","family":"Zhong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-Bao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Wei","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Tan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Wei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Xian","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Hui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,25]]},"reference":[{"key":"14913_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"14913_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jncc.2022.02.002","volume":"2","author":"R Zheng","year":"2022","unstructured":"Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Center. 2022;2:1\u20139.","journal-title":"J Natl Cancer Center"},{"key":"14913_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jcsm.12484","volume":"11","author":"UT Hacker","year":"2020","unstructured":"Hacker UT, Hasenclever D, Linder N, et al. Prognostic role of body composition parameters in gastric\/gastroesophageal junction cancer patients from the EXPAND trial. J Cachexia Sarcopenia Muscle. 2020;11:135\u201344.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"14913_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12234","author":"MH Choi","year":"2017","unstructured":"Choi MH, Oh SN, Lee IK, et al. Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer. J Cachexia. 2017. https:\/\/doi.org\/10.1002\/jcsm.12234.","journal-title":"J Cachexia"},{"key":"14913_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1111\/j.1440-1681.2007.04752.x","volume":"34","author":"JA Faulkner","year":"2010","unstructured":"Faulkner JA, Larkin LM, Claflin DR, Brooks SV. Age-related changes in the structure and function of skeletal muscles. Clin Exper Pharmacol Physiol. 2010;34:1091\u20136.","journal-title":"Clin Exper Pharmacol Physiol"},{"issue":"6","key":"14913_CR6","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1001\/jamaoncol.2018.0137","volume":"4","author":"BJ Caan","year":"2018","unstructured":"Caan BJ, Feliciano EMC, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of muscle and adiposity measured by computed tomography with survival in patients with nonmetastatic breast cancer. JAMA Oncol. 2018;4(6):798\u2013804.","journal-title":"JAMA Oncol"},{"key":"14913_CR7","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","volume":"31","author":"L Martin","year":"2013","unstructured":"Martin L, Birdsell L, MacDonald N, et al. Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol. 2013;31:1539\u201347.","journal-title":"J Clin Oncol"},{"key":"14913_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s12603-010-0081-2","volume":"14","author":"RL Marcus","year":"2010","unstructured":"Marcus RL, Addison O, Kidde JP, et al. Skeletal muscle fat infiltration: impact of age, inactivity, and exercise. J Nutr Health Aging. 2010;14:362.","journal-title":"J Nutr Health Aging"},{"key":"14913_CR9","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1002\/jcsm.12771","volume":"12","author":"M Schneider","year":"2021","unstructured":"Schneider M, H\u00fcbner M, Becce F, et al. Sarcopenia and major complications in patients undergoing oncologic colon surgery. J Cachexia Sarcopenia Muscle. 2021;12:1757.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"14913_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tbj.12952","volume":"24","author":"MS Weinberg","year":"2018","unstructured":"Weinberg MS, Shachar SS, Muss HB, et al. Beyond sarcopenia: characterization and integration of skeletal muscle quantity and radiodensity in a curable breast cancer population. Breast J. 2018;24:278.","journal-title":"Breast J"},{"key":"14913_CR11","doi-asserted-by":"publisher","first-page":"e2139992","DOI":"10.1001\/jamanetworkopen.2021.39992","volume":"4","author":"C Zheng","year":"2021","unstructured":"Zheng C, Xu Y, Zhao G, et al. Outcomes of laparoscopic total gastrectomy combined with spleen-preserving hilar lymphadenectomy for locally advanced proximal gastric cancer: a nonrandomized clinical trial. JAMA Netw Open. 2021;4:e2139992\u2013e2139992.","journal-title":"JAMA Netw Open"},{"key":"14913_CR12","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.surg.2017.09.053","volume":"163","author":"CH Zheng","year":"2018","unstructured":"Zheng CH, Lu J, Zheng HL, et al. Comparison of 3D laparoscopic gastrectomy with a 2D procedure for gastric cancer: a phase 3 randomized controlled trial. Surgery. 2018;163:300.","journal-title":"Surgery"},{"key":"14913_CR13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/jamasurg.2022.5307","volume":"158","author":"J-X Lin","year":"2022","unstructured":"Lin J-X, Lin J-P, Wang Z-K, et al. Assessment of laparoscopic spleen-preserving hilar lymphadenectomy for advanced proximal gastric cancer without invasion into the greater curvature: a randomized clinical trial. JAMA Surg. 2022;158:10.","journal-title":"JAMA Surg"},{"key":"14913_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer Association","year":"2021","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1\u201321. https:\/\/doi.org\/10.1007\/s10120-020-01042-y.","journal-title":"Gastric Cancer"},{"key":"14913_CR15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1139\/H08-075","volume":"33","author":"M Mourtzakis","year":"2008","unstructured":"Mourtzakis M, Prado C, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab. 2008;33:997\u20131006.","journal-title":"Appl Physiol Nutr Metab."},{"key":"14913_CR16","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1002\/jcsm.12573","volume":"11","author":"E Feliciano","year":"2020","unstructured":"Feliciano E, Popuri K, Cobzas D, et al. Evaluation of automated computed tomography segmentation to assess body composition and mortality associations in cancer patients. J Cachexia, Sarcopenia Muscle. 2020;11:1258.","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"14913_CR17","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1093\/ajcn\/48.6.1351","volume":"48","author":"H Kvist","year":"1988","unstructured":"Kvist H, Chowdhury B, Grangrd U, et al. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr. 1988;48:1351\u201361.","journal-title":"Am J Clin Nutr"},{"key":"14913_CR18","unstructured":"Organization WH. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organization technical report series 1995; 854"},{"issue":"1","key":"14913_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10120-020-01042-y","volume":"24","author":"Japanese Gastric Cancer Association","year":"2020","unstructured":"Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018. Gastric cancer. 2020;24(1):1\u201321.","journal-title":"Gastric cancer"},{"key":"14913_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205\u201313.","journal-title":"Ann Surg"},{"key":"14913_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1093\/annonc\/mdu360","volume":"26","author":"C Bellera","year":"2015","unstructured":"Bellera C, Penel N, Ouali M, et al. Definition for the Assessment of time-to-event endpoints in Cancer Trials Initiative: guidelines for time-to-event end point definitions in sarcomas and gastrointestinal stromal tumors (GIST) trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials). Ann Oncol. 2015;26:865.","journal-title":"Ann Oncol"},{"key":"14913_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","volume":"22","author":"J Kondrup","year":"2003","unstructured":"Kondrup J, Rasmussen HH, Hamberg O, et al. Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr. 2003;22:321\u201336.","journal-title":"Clin Nutr"},{"key":"14913_CR23","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ctrv.2013.06.007","volume":"40","author":"LM Buffart","year":"2014","unstructured":"Buffart LM, Galv\u00e3o DA, Brug J, et al. Evidence-based physical activity guidelines for cancer survivors: current guidelines, knowledge gaps, and future research directions. Cancer Treat Rev. 2014;40:327\u201340.","journal-title":"Cancer Treat Rev"},{"key":"14913_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.09.009","author":"S Nachiappan","year":"2004","unstructured":"Nachiappan S, Askari A, Mamidanna R, et al. The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection. Eur J Surg Oncol. 2015. https:\/\/doi.org\/10.1016\/j.ejso.2015.09.009.","journal-title":"Eur J Surg Oncol"},{"key":"14913_CR25","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","volume":"10","author":"RL Camp","year":"2004","unstructured":"Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252\u20139.","journal-title":"Clin Cancer Res"},{"key":"14913_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.09.006","author":"N Lou","year":"2016","unstructured":"Lou N, Chi CH, Chen XD, et al. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: a prospective study. Eur J Surg Oncol. 2016. https:\/\/doi.org\/10.1016\/j.ejso.2016.09.006.","journal-title":"Eur J Surg Oncol"},{"key":"14913_CR27","doi-asserted-by":"publisher","first-page":"3537","DOI":"10.1002\/cam4.1548","volume":"7","author":"ZF Zheng","year":"2018","unstructured":"Zheng ZF, Lu J, Xie JW, et al. Preoperative skeletal muscle index vs the controlling nutritional status score: which is a better objective predictor of long-term survival for gastric cancer patients after radical gastrectomy? Cancer Med. 2018;7:3537.","journal-title":"Cancer Med"},{"issue":"300\u20137","key":"14913_CR28","first-page":"E302","volume":"21","author":"L-K Chen","year":"2020","unstructured":"Chen L-K, Woo J, Assantachai P, et al. Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Directors Assc. 2020;21(300\u20137):E302.","journal-title":"J Am Med Directors Assc"},{"key":"14913_CR29","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/jcsm.12831","volume":"12","author":"J McGovern","year":"2021","unstructured":"McGovern J, Dolan RD, Horgan PG, et al. Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review. J Cachexia Sarcopenia Muscle. 2021;12:1408\u201317.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"14913_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/jso.24015","volume":"112","author":"J Tegels","year":"2015","unstructured":"Tegels J, Vugt JV, Reisinger KW, et al. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes. J Surg Oncol. 2015;112:403\u20137.","journal-title":"J Surg Oncol"},{"issue":"2","key":"14913_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/jcsm.12155","volume":"8","author":"DP van Dijk","year":"2017","unstructured":"van Dijk DP, Bakens MJ, Coolsen MM, Rensen SS, van Dam RM, Bours MJ, et al. Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(2):317\u201326.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"14913_CR32","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1017\/S0007114512001067","volume":"109","author":"KMD Sebastiano","year":"2013","unstructured":"Sebastiano KMD, Yang L, Zbuk K, et al. Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia. Br J Nutr. 2013;109:302\u201312.","journal-title":"Br J Nutr"},{"key":"14913_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2022-003387","author":"C Polen-De","year":"2022","unstructured":"Polen-De C, Fadadu P, Weaver AL, et al. Quality is more important than quantity: preoperative sarcopenia is associated with poor survival in advanced ovarian cancer. Int J Gynecol Cancer. 2022. https:\/\/doi.org\/10.1136\/ijgc-2022-003387.","journal-title":"Int J Gynecol Cancer"},{"issue":"5","key":"14913_CR34","doi-asserted-by":"publisher","first-page":"B267","DOI":"10.1093\/gerona\/52A.5.B267","volume":"52","author":"ME Jeffrey","year":"1997","unstructured":"Jeffrey ME, Robin C, Jordan T, et al. Age-associated loss of power and strength in the upper extremities in women and men. J Gerontol A Biol Sci Med Sci. 1997;52(5):B267\u201376. https:\/\/doi.org\/10.1093\/gerona\/52A.5.B267.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"14913_CR35","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1159\/000211949","volume":"55","author":"P-O Lang","year":"2009","unstructured":"Lang P-O, Michel J-P, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology. 2009;55:539\u201349.","journal-title":"Gerontology"},{"key":"14913_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/ajcn\/54.3.509","volume":"54","author":"DE Kelley","year":"1991","unstructured":"Kelley DE, Slasky BS, Janosky J. Skeletal muscle density: effects of obesity and non-insulin-dependent diabetes mellitus. Am J Clin Nutr. 1991;54:509\u201315.","journal-title":"Am J Clin Nutr"},{"key":"14913_CR37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1097\/SPC.0000000000000011","volume":"7","author":"S Antoun","year":"2013","unstructured":"Antoun S, Borget I, Lanoy E. Impact of sarcopenia on the prognosis and treatment toxicities in patients diagnosed with cancer. Curr Opin Support Palliat Care. 2013;7:383\u20139.","journal-title":"Curr Opin Support Palliat Care"},{"key":"14913_CR38","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1158\/1078-0432.CCR-16-0940","volume":"23","author":"SS Shachar","year":"2017","unstructured":"Shachar SS, Deal AM, Weinberg M, et al. Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy: skeletal muscle and outcomes in metastatic breast cancer. Clin Cancer Res. 2017;23:658\u201365.","journal-title":"Clin Cancer Res"},{"key":"14913_CR39","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1470-2045(08)70153-0","volume":"9","author":"C Prado","year":"2008","unstructured":"Prado C, Lieffers JR, Mccargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol. 2008;9:605\u20137.","journal-title":"Lancet Oncol"},{"key":"14913_CR40","doi-asserted-by":"publisher","first-page":"4387","DOI":"10.1200\/JCO.2011.36.5908","volume":"29","author":"M Sasako","year":"2011","unstructured":"Sasako M, Sakuramoto S, Katai H, et al. Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol. 2011;29:4387\u201393.","journal-title":"J Clin Oncol"},{"key":"14913_CR41","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s10147-017-1089-y","volume":"22","author":"T Aoyama","year":"2017","unstructured":"Aoyama T, Sato T, Maezawa Y, et al. Postoperative weight loss leads to poor survival through poor S-1 efficacy in patients with stage II\/III gastric cancer. Int J Clin Oncol. 2017;22:476\u201383.","journal-title":"Int J Clin Oncol"}],"updated-by":[{"DOI":"10.1245\/s10434-024-15069-3","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-024-14913-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-024-14913-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:04:32Z","timestamp":1712333072000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-024-14913-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,25]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["14913"],"URL":"https:\/\/doi.org\/10.1245\/s10434-024-14913-w","relation":{"correction":[{"id-type":"doi","id":"10.1245\/s10434-024-15069-3","asserted-by":"object"}]},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,25]]},"assertion":[{"value":"16 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-024-15069-3","URL":"https:\/\/doi.org\/10.1245\/s10434-024-15069-3","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}